98 related articles for article (PubMed ID: 6403789)
1. Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy.
Baraldi M; Zeneroli ML; Ricci P; Caselgrandi E; Ventura E
Life Sci; 1983 Mar; 32(13):1417-25. PubMed ID: 6403789
[TBL] [Abstract][Full Text] [Related]
2. Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy.
Zeneroli ML; Baraldi M; Ventura E; Vezzelli C; Tofanetti O; Germini M; Casciarri I
Life Sci; 1991; 48(1):37-50. PubMed ID: 1846016
[TBL] [Abstract][Full Text] [Related]
3. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
Zeneroli ML
J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
[TBL] [Abstract][Full Text] [Related]
4. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
[TBL] [Abstract][Full Text] [Related]
5. Reversible decrease of dopamine D2 receptor density in the striatum of rats with acute hepatic failure.
Waśkiewicz J; Freśko I; Lenkiewicz A; Albrecht J
Brain Res; 2001 May; 900(1):143-5. PubMed ID: 11325357
[TBL] [Abstract][Full Text] [Related]
6. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
Korf J; Sebens JB; Flentge F; van der Werf JF
J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
[TBL] [Abstract][Full Text] [Related]
7. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
8. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
9. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
Noisin EL; Thomas WE
Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
[TBL] [Abstract][Full Text] [Related]
11. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
De Vries DJ; Beart PM
Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
[TBL] [Abstract][Full Text] [Related]
12. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
Korf J; Sebens JB
J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
[TBL] [Abstract][Full Text] [Related]
13. Lateralization of striatal dopamine (D2) receptors in normal rats.
Schneider LH; Murphy RB; Coons EE
Neurosci Lett; 1982 Dec; 33(3):281-4. PubMed ID: 7162690
[TBL] [Abstract][Full Text] [Related]
14. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
Clements-Jewery S; Robson PA
Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
[No Abstract] [Full Text] [Related]
15. Dopamine receptor binding is increased in diabetic rats.
Lozovsky D; Saller CF; Kopin IJ
Science; 1981 Nov; 214(4524):1031-3. PubMed ID: 6458088
[TBL] [Abstract][Full Text] [Related]
16. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary.
Serri O; Renier G; Somma M
Horm Res; 1985; 21(2):95-101. PubMed ID: 3979949
[TBL] [Abstract][Full Text] [Related]
17. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
[TBL] [Abstract][Full Text] [Related]
18. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors.
Owen F; Poulter M; Mashal RD; Crow TJ; Veall N; Zanelli GD
Life Sci; 1983 Aug; 33(8):765-8. PubMed ID: 6888192
[TBL] [Abstract][Full Text] [Related]
19. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
Hruska RE
J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
